Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15400-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15400-1-AP, RRID:AB_2184321
- Product name
- SATB1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated SATB1 antibody (Cat. #15400-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references SATB1/SLC7A11/HO-1 Axis Ameliorates Ferroptosis in Neuron Cells After Ischemic Stroke by Danhong Injection.
SATB1 regulates 3D genome architecture in T cells by constraining chromatin interactions surrounding CTCF-binding sites.
Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways.
SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Effect of STAT3 mediated epigenetic regulation in pre-eclampsia: an analysis of trial data.
Silencing SATB1 influences cell invasion, migration, proliferation, and drug resistance in nasopharyngeal carcinoma.
Zhan S, Liang J, Lin H, Cai J, Yang X, Wu H, Wei J, Wang S, Xian M
Molecular neurobiology 2023 Jan;60(1):413-427
Molecular neurobiology 2023 Jan;60(1):413-427
SATB1 regulates 3D genome architecture in T cells by constraining chromatin interactions surrounding CTCF-binding sites.
Wang B, Ji L, Bian Q
Cell reports 2023 Apr 25;42(4):112323
Cell reports 2023 Apr 25;42(4):112323
Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways.
Cai J, Liang J, Zhang Y, Shen L, Lin H, Hu T, Zhan S, Xie M, Liang S, Xian M, Wang S
Pharmacological research 2022 Jun;180:106230
Pharmacological research 2022 Jun;180:106230
SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D, Ye C, Pan Z, Deng Y
International journal of medical sciences 2021;18(1):42-52
International journal of medical sciences 2021;18(1):42-52
Effect of STAT3 mediated epigenetic regulation in pre-eclampsia: an analysis of trial data.
Zhang XL, Pan J, Wang G, Li H, Wang JL, Jiang XM, Zhao XY
European review for medical and pharmacological sciences 2020 Jun;24(11):5843-5855
European review for medical and pharmacological sciences 2020 Jun;24(11):5843-5855
Silencing SATB1 influences cell invasion, migration, proliferation, and drug resistance in nasopharyngeal carcinoma.
Ye CS, Zhou DN, Yang QQ, Deng YF
International journal of clinical and experimental pathology 2014;7(3):914-22
International journal of clinical and experimental pathology 2014;7(3):914-22
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The SATB1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human SATB1. This antibody recognizes human, mouse, rat antigen. The SATB1 antibody has been validated for the following applications: ELISA, WB analysis.